지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2019.1
- 수록면
- 383 - 384 (2page)
이용수
초록· 키워드
오류제보하기
등록된 정보가 없습니다.
목차
등록된 정보가 없습니다.
참고문헌 (7)
참고문헌 신청
Ballestri S / 2016 / Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome : evidence from a systematic review and meta-analysis / J Gastroenterol Hepatol 31:936~944
Mantovani A / 2018 / Nonalcoholic fatty liver disease and risk of incident type 2 diabetes : a meta-analysis / Diabetes Care 41:372~382
Hyo Jung Cho / 2019 / Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus / Gut and Liver 13(4):440~449
Sung KC / 2013 / Resolution of fatty liver and risk of incident diabetes / J Clin Endocrinol Metab 98:3637~3643
Yamazaki H / 2015 / Independent association between improvement of nonalcoholic fatty liver disease and reduced incidence of type 2 diabetes / Diabetes Care 38:1673~1679
Mantovani A / 2018 / Nonalcoholic fatty liver disease and risk of incident type 2 diabetes : a meta-analysis / Diabetes Care 41:372~382
Hyo Jung Cho / 2019 / Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus / Gut and Liver 13(4):440~449
Sung KC / 2013 / Resolution of fatty liver and risk of incident diabetes / J Clin Endocrinol Metab 98:3637~3643
Yamazaki H / 2015 / Independent association between improvement of nonalcoholic fatty liver disease and reduced incidence of type 2 diabetes / Diabetes Care 38:1673~1679
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Implications of comorbidities in nonalcoholic fatty liver disease
Clinical and Molecular Hepatology
2023 .04
-
Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2022;46:630-9)
Diabetes and Metabolism Journal
2022 .11
-
Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2022;46:630-9)
Diabetes and Metabolism Journal
2022 .11
-
Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
Clinical and Molecular Hepatology
2023 .04
-
Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2021;45:698-707)
Diabetes and Metabolism Journal
2021 .11
-
Sarcopenia as a Novel Risk Factor for Nonalcoholic Fatty Liver Disease
Journal of Obesity & Metabolic Syndrome
2020 .01
-
The effect of moderate alcohol consumption on nonalcoholic fatty liver disease
Clinical and Molecular Hepatology
2023 .04
-
The Impact of Body Composition on the Prognosis of Nonalcoholic Fatty Liver Disease
Gut and Liver
2024 .07
-
Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2021;45:698-707)
Diabetes and Metabolism Journal
2021 .11
-
A crystal ball to forecast treatment responsiveness in nonalcoholic fatty liver disease
Clinical and Molecular Hepatology
2022 .07
-
Personalized medicine in nonalcoholic fatty liver disease
Clinical and Molecular Hepatology
2022 .10
-
Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations
Clinical and Molecular Hepatology
2022 .10
-
The growing burden of non-alcoholic fatty liver disease on mortality
Clinical and Molecular Hepatology
2023 .04
-
Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment
Diabetes and Metabolism Journal
2019 .01
-
Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time?
Clinical and Molecular Hepatology
2022 .01
-
Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?
Clinical and Molecular Hepatology
2023 .04
-
Probiotics for treatment of nonalcoholic fatty liver disease: It is worth a try
Clinical and Molecular Hepatology
2021 .01
-
Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
Clinical and Molecular Hepatology
2023 .02
-
Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
Diabetes and Metabolism Journal
2022 .07
-
Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology
Clinical and Molecular Hepatology
2023 .04
이 논문의 저자 정보
최근 본 자료
댓글(0)
0